Skip to content

Study · Case report or series · n = 1 · 2024

1 result

Clinical Manifestations of Semaglutide Overdose: A Case Study.

Branch MR, Amador IE, Tardif I, Patel KK, Lewis DA

Journal of psychiatric practice1 Nov 2024Cited by 1 (Europe PMC)

PMID39655973 (opens in a new tab)DOI10.1097/pra.0000000000000824 (opens in a new tab)PepBankPUB-39655973
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In one adult who took an intentional overdose of semaglutide, symptoms were mild and self-limiting.

    In plain wordsIn one adult who took too much semaglutide on purpose, the symptoms were mild and went away on their own.

    Peptide
    Semaglutide
    Outcome
    Not applicableSymptoms after intentional semaglutide overdose
    Study

    n = 1

    Outcome group
    Adverse events · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Her symptoms after the overdose were mild and self-limiting in nature.
    1 context sentence
    Summary · context
    We present the case of a 39-year-old transgender male-to-female who attempted suicide by an intentional overdose of semaglutide (Ozempic).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.